The IMPACTCABG trial A multicenter randomized clinical trial
The IMPACT-CABG trial: A multicenter, randomized clinical trial of CD 133+ stem cell therapy during coronary artery bypass grafting for ischemic cardiomyopathy Nicolas Noiseux, MD, MSc, Samer Mansour, MD, Richard Weisel, MD, Louis-Mathieu Stevens, MD, Ph. D, Shant Der Sarkissian, Ph. D, Katherine Tsang, RN, MN, Andrew M. Crean, MRCP, Eric Larose, MD, Shu-Hong Li, MD, Bernd Wintersperger, MD, Minh Quan Vu, MD, Ignacio Prieto, MD, Ren-Ke Li, MD, Ph. D, Denis Claude Roy, MD, Terrence M. Yau, MD, MSc The Journal of Thoracic and Cardiovascular Surgery Volume 152 Issue 6 Pages 1582 -1588. e 2 (December 2016) DOI: 10. 1016/j. jtcvs. 2016. 07. 067 Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions
Figure 1 The Journal of Thoracic and Cardiovascular Surgery 2016 1521582 -1588. e 2 DOI: (10. 1016/j. jtcvs. 2016. 07. 067) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions
Figure E 1 The Journal of Thoracic and Cardiovascular Surgery 2016 1521582 -1588. e 2 DOI: (10. 1016/j. jtcvs. 2016. 07. 067) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions
The Journal of Thoracic and Cardiovascular Surgery 2016 1521582 -1588. e 2 DOI: (10. 1016/j. jtcvs. 2016. 07. 067) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions
Video 1 The Journal of Thoracic and Cardiovascular Surgery 2016 1521582 -1588. e 2 DOI: (10. 1016/j. jtcvs. 2016. 07. 067) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions
- Slides: 5